2.5mg tirze as maintenance after goal weight — anyone running this long term?

T
Joined 2026
16 posts
3/18/2026 · 1825 views

Hit goal weight at 165lb (from 214). Currently at 10mg. Plan is to step down to 5, then maintenance at 2.5mg indefinitely rather than come fully off. Logic: 2.5 is below the therapeutic weight-loss threshold but still delivers meaningful appetite suppression and metabolic benefit. Should prevent rebound without any of the fast-loss dynamics.

Anyone actually running 2.5 as indefinite maintenance? How long?

6 Replies

S
Joined 2026
25 posts
3/19/2026

2.5 maintenance, 18 months. Weight stable within 3lb. Side effects basically zero. Monthly cost reasonable. Best decision I made was not trying to come off fully.

M
Joined 2026
29 posts
29d ago

Running 2mg tirze weekly (lower than 2.5) for similar reasons. Maintenance is easier at below-therapeutic dose because you're not trying to suppress appetite aggressively — you're just keeping the metabolic signal on.

G
Joined 2026
32 posts
28d ago

The 'maintenance microdose' approach is increasingly discussed among providers. Not label, but plausible mechanism, and avoids the STEP-4 / SURMOUNT-4 style rebound that occurred in cohorts that came fully off. The counterargument is indefinite drug exposure — long-term safety on chronic low-dose is still being established.

C
Joined 2026
19 posts
cagrisemaMember
27d ago

Stacking 2.5 tirze with microdose cagrilintide (0.5mg weekly) for maintenance has been my setup for 8 months. The amylin component further smooths satiety. If you're going to stay on something indefinitely, might as well pick a clean dual-agonist approach.

S
Joined 2026
115 posts
26d ago

No long-term data on chronic low-dose GLP-1/GIP exposure beyond ~5 years. Everyone running indefinite maintenance is in post-trial territory. The choice is reasonable, just state it as 'less data here than active-phase dosing.'

D
Joined 2025
119 posts
dr_doubtRegular
24d ago

The real question is what you're optimizing for. If lifetime weight regulation and the drug has a favorable safety profile at low dose, indefinite maintenance may be appropriate. If you're philosophically committed to 'off all drugs' as an endpoint, you'll need to build a behavioral protocol that replaces what the drug was doing — and that's a bigger project than most people bargain for.

Sign in to reply.